Cargando…
Fungal co-infection in COVID-19 patients: evidence from a systematic review and meta-analysis
Coronavirus disease 2019 (COVID-19) has infected tens of millions of people worldwide within the last year. However, the incidence of fungal co-infection in COVID-19 patients remains unclear. To investigate the association between fungal co-infection and mortality due to COVID-19, we systematically...
Autores principales: | Peng, Jingwen, Wang, Qiong, Mei, Huan, Zheng, Hailin, Liang, Guangzhao, She, Xiaodong, Liu, Weida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034918/ https://www.ncbi.nlm.nih.gov/pubmed/33744863 http://dx.doi.org/10.18632/aging.202742 |
Ejemplares similares
-
Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis
por: Peng, Jingwen, et al.
Publicado: (2022) -
Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis
por: Peng, Jingwen, et al.
Publicado: (2021) -
Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis
por: Zhang, Jingyun, et al.
Publicado: (2022) -
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis
por: Zhang, Jingyun, et al.
Publicado: (2022) -
Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China
por: Song, Ge, et al.
Publicado: (2020)